159 related articles for article (PubMed ID: 32703192)
21. Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis.
Carvalho RD; Breyner N; Menezes-Garcia Z; Rodrigues NM; Lemos L; Maioli TU; da Gloria Souza D; Carmona D; de Faria AM; Langella P; Chatel JM; Bermúdez-Humarán LG; Figueiredo HC; Azevedo V; de Azevedo MS
Microb Cell Fact; 2017 Feb; 16(1):27. PubMed ID: 28193209
[TBL] [Abstract][Full Text] [Related]
22. Lactococcus lactis, a tool for the delivery of therapeutic proteins treatment of IBD.
Steidler L
ScientificWorldJournal; 2001 May; 1():216-7. PubMed ID: 12805677
[TBL] [Abstract][Full Text] [Related]
23. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model.
del Carmen S; Martín Rosique R; Saraiva T; Zurita-Turk M; Miyoshi A; Azevedo V; de Moreno de LeBlanc A; Langella P; Bermúdez-Humarán LG; LeBlanc JG
J Clin Gastroenterol; 2014; 48 Suppl 1():S12-7. PubMed ID: 25291117
[TBL] [Abstract][Full Text] [Related]
24. Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci.
Bermúdez-Humarán LG; Motta JP; Aubry C; Kharrat P; Rous-Martin L; Sallenave JM; Deraison C; Vergnolle N; Langella P
Microb Cell Fact; 2015 Feb; 14():26. PubMed ID: 25889561
[TBL] [Abstract][Full Text] [Related]
25. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.
Steidler L; Hans W; Schotte L; Neirynck S; Obermeier F; Falk W; Fiers W; Remaut E
Science; 2000 Aug; 289(5483):1352-5. PubMed ID: 10958782
[TBL] [Abstract][Full Text] [Related]
26. Secretion and surface display of binders of IL-23/IL-17 cytokines and their receptors in Lactococcus lactis as a therapeutic approach against inflammation.
Plavec TV; Klemenčič K; Kuchař M; Malý P; Berlec A
Eur J Pharm Sci; 2023 Nov; 190():106568. PubMed ID: 37619953
[TBL] [Abstract][Full Text] [Related]
27. Oral delivery of Lactococcus lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in mice.
Shigemori S; Watanabe T; Kudoh K; Ihara M; Nigar S; Yamamoto Y; Suda Y; Sato T; Kitazawa H; Shimosato T
Microb Cell Fact; 2015 Nov; 14():189. PubMed ID: 26608030
[TBL] [Abstract][Full Text] [Related]
28. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
29. Hsp65-Producing
Gusmao-Silva G; Aguiar SLF; Miranda MCG; Guimarães MA; Alves JL; Vieira AT; Cara DC; Miyoshi A; Azevedo VA; Oliveira RP; Faria AMC
Front Immunol; 2020; 11():562905. PubMed ID: 33072101
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the biosafety of recombinant lactic acid bacteria designed to prevent and treat colitis.
de Moreno de LeBlanc A; Del Carmen S; Chatel JM; Azevedo V; Langella P; Bermudez-Humaran L; LeBlanc JG
J Med Microbiol; 2016 Sep; 65(9):1038-1046. PubMed ID: 27469354
[TBL] [Abstract][Full Text] [Related]
31. Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization.
Li HS; Piao DC; Jiang T; Bok JD; Cho CS; Lee YS; Kang SK; Choi YJ
Vaccine; 2015 Apr; 33(16):1959-67. PubMed ID: 25738814
[TBL] [Abstract][Full Text] [Related]
32. Lactococcus lactis Administration Modulates IgE and IL-4 Production and Promotes Enterobacteria Growth in the Gut from Ethanol-Intake Mice.
Athayde LA; de Aguiar SLF; Miranda MCG; Brito RVJ; de Faria AMC; Nobre SAM; Andrade MC
Protein Pept Lett; 2021; 28(10):1164-1179. PubMed ID: 34315363
[TBL] [Abstract][Full Text] [Related]
33. Immunomodulatory effects of different strains of Lactococcus lactis in DSS-induced colitis.
Alves JL; Lemos L; Rodrigues NM; Pereira VB; Barros PAV; Canesso MCC; Guimarães MAF; Cara DC; Miyoshi A; Azevedo VA; Maioli TU; Gomes-Santos AC; Faria AMC
Braz J Microbiol; 2023 Jun; 54(2):1203-1215. PubMed ID: 36821043
[TBL] [Abstract][Full Text] [Related]
34. Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice.
Jing H; Yong L; Haiyan L; Yanjun M; Yun X; Yu Z; Taiming L; Rongyue C; Liang J; Jie W; Li Z; Jingjing L
Vaccine; 2011 May; 29(24):4102-9. PubMed ID: 21497632
[TBL] [Abstract][Full Text] [Related]
35. Trimming of two major type 1 diabetes driving antigens, GAD65 and IA-2, allows for successful expression in Lactococcus lactis.
Robert S; Van Huynegem K; Gysemans C; Mathieu C; Rottiers P; Steidler L
Benef Microbes; 2015; 6(4):591-601. PubMed ID: 25576592
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo characterization of DNA delivery using recombinant Lactococcus lactis expressing a mutated form of L. monocytogenes Internalin A.
de Azevedo M; Karczewski J; Lefévre F; Azevedo V; Miyoshi A; Wells JM; Langella P; Chatel JM
BMC Microbiol; 2012 Dec; 12():299. PubMed ID: 23253484
[TBL] [Abstract][Full Text] [Related]
37. Targeting IL-6 by engineered Lactococcus lactis via surface-displayed affibody.
Zahirović A; Berlec A
Microb Cell Fact; 2022 Jul; 21(1):143. PubMed ID: 35842694
[TBL] [Abstract][Full Text] [Related]
38. Development of a Stress-Inducible Controlled Expression (SICE) system in Lactococcus lactis for the production and delivery of therapeutic molecules at mucosal surfaces.
Benbouziane B; Ribelles P; Aubry C; Martin R; Kharrat P; Riazi A; Langella P; Bermúdez-Humarán LG
J Biotechnol; 2013 Oct; 168(2):120-9. PubMed ID: 23664884
[TBL] [Abstract][Full Text] [Related]
39.
de Castro CP; Souza BM; Mancha-Agresti P; Pereira VB; Zurita-Turk M; Preisser TM; da Cunha VP; Dos Santos JSC; Leclercq SY; Azevedo V; Miyoshi A
Front Microbiol; 2021; 12():676172. PubMed ID: 34093498
[TBL] [Abstract][Full Text] [Related]
40. In situ delivery of cytokines by genetically engineered Lactococcus lactis.
Steidler L
Antonie Van Leeuwenhoek; 2002 Aug; 82(1-4):323-31. PubMed ID: 12369199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
